ResearchMoz

Bioactive Wound Care Market in the US 2012-2016

Technavio
Published Date » 2013-09-06
No. Of Pages » 42
   
 TechNavio's analysts forecast the Bioactive Wound Care market in the US to grow at a CAGR of 5.26 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in elderly population in the US. The Bioactive Wound Care market in the US has also been witnessing an increasing adoption of antimicrobial dressings. However, the presence of substitutes to bioactive wound care products could pose a challenge to the growth of this market. 
   
 TechNavio's report, the Bioactive Wound Care Market in the US 2012-2016 has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the Bioactive Wound Care market in the US and its growth prospects in the coming years. The report also...
TABLE OF CONTENT

1.  Executive Summary

2. List of Abbreviations

3. Introduction

4. Market Research Methodology
Market Research Process
Research Design
Research Methodology

5. Scope of the Report
Market Overview
Product Offerings

6. Market Landscape
6.1 Bioactive Wound Care Market in the US
Market Size and Forecast
Market Segmentation by Wound Dressing Material
6.2 Five Forces Analysis

7. Vendor Landscape

8. Buying Criteria

9. Market Growth Drivers

10. Drivers and their Impact

11. Market Challenges

12. Impact of Drivers and Challenges

13. Market Trends

14. Key Vendor Analysis
14.1 3M Health Care
Business Overview
Business Segmentation
Key Information
SWOT Analysis
14.2 ConvaTec Inc.
Business Overview
Business Segmentation
Key Information
SWOT Analysis
14.3 Molnlycke Health Care AB
Business Overview
Business Segmentation
Key Information
SWOT Analysis
14.4 Smith & Nephew plc
Business Overview
Business Segmentation
Key Information
SWOT Analysis

15. Other Reports in this Series

List of Tables

NA

List of Figures


Exhibit 1:  Market Research Methodology
Exhibit 2: Bioactive Wound Care Market in the US 2012-2016 (US$ billion)
Exhibit 3: Market Segmentation by Wound Dressing Material
Exhibit 4: Business Segmentation of 3M Health Care
Exhibit 5: Business Segmentation of ConvaTec Inc.
Exhibit 6: Business Segmentation of Molnlycke Health Care AB
Exhibit 7: Business Segmentation of Smith & Nephew plc

Upcoming Reports:

Orphan Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018
By - Transparency Market Research
Orphan drugs are specific pharmaceutical agents which are developed for treatment of orphan or rare diseases. Orphan disease, according to laws of various countries, may include medical conditions which have low prevalence, i.e. affects less than 200,000 persons (U.S.), or 50,000 (Japan). Expiring patents of blockbuster drugs, drying pipelines, stringent regulations across the globe, has encouraged the pharmaceutical industries to shift the focus to a new business model that includes niche busters or orphan drugs.  Currently, around 7,000 diseases are recognized as orphan...
Cystic Fibrosis (CF) Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Cystic fibrosis (CF), also known as mucoviscidosis, is autosomal recessive disorder that is characterized by abnormal transport of chloride and sodium across an epithelium. The occurrence of disease leads to thick and viscous secretions which causes a life threatening impact on the lungs, the pancreas, liver, and intestine, and also blocks the pancreatic enzymatic actions on the body. Cystic fibrosis is caused by mutation in gene, required for protein cystic fibrosis transmembrane conductance regulator (CFTR), a protein required for regulating sweat, mucus and body secretions. The market...
Anthocyanin Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Anthocyanin is a water soluble flavonoid pigment with red, blue or purple appearance depending on its pH. Anthocyanin is flavorless and odorless. It is found in fruits and vegetables such as berries, cabbage, purple grapes and beets among others. Anthocyanin acts as an antioxidant, anti-allergic, anti-inflammatory, anti-microbial, and microcirculation improvement. The market for anthocyanin is divided into various types such as antioxidant market, natural colorant, colors and viscosity modifier among others. The market for anthocyanin was mainly driven by antioxidant market. Anthocyanin...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Order cancellations not a sign of market slump: Airbus
Jul 31, 2014  
Leading aircraft manufacturer Airbus on Wednesday said that the recent wave of order cancellations for its commercial jetliners do not mean that the market has declined. The market is still strong and single-aisle jets deals are likely to return later. A total of 225 Airbus cancellations were reported since the beginning of this year. Of these, Dubai’s Emirates Airlines alone...
Leading Australian Universities Want to Hike Fees, Enroll Fewer Students
Jul 31, 2014  
Australia’s prestigious group of top eight universities, also known as the Group of Eight (Go8), has indicated plans of increasing tuition fees while reducing the number of students they enroll, a reform-backer has predicted. These decisions could be made if the universities are deregulated .  Arguing for this decision, the chairman of Go8, and vice chancellor of the ANU, Ian...
Blackstone Invests $800 Million in Asian Oil-Based Energy Company
Jul 31, 2014  
Blackstone Energy Partners announced to invest $800 million in an Asian based energy company that is led by former industry executives.  Blackstone is popularly considered a part of the world’s largest administrator of alternatives to financial stocks and bonds. New York-based managing director, Angelo Acconcia of Blackstone Energy Partners said in an interview that Tamarind...
Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...